Lauren Boreta

Lauren Boreta

Lauren Boreta, M.D.

Clinical Instructor
Department of Radiation Oncology

University of California, San Francisco
505 Parnassus Avenue, Room L-08
San Francisco, CA 94143
Phone: 415-353-8949
Fax: 415-353-8679
Email: Lauren.Boreta@ucsf.edu

Make A Gift Button

 

Professional Focus

Dr. Lauren Boreta, M.D. is a radiation oncologist with clinical interest in radiation for palliation of advanced cancer and treatment of central nervous system malignancies. Dr. Boreta graduated from Stanford University and subsequently received her medical degree from UCSF. She completed an internship in internal medicine at Kaiser Permanente San Francisco, and in 2019 completed her residency in Radiation Oncology at UCSF. Her research interests include utilization and efficacy of palliative radiation, cancer-care disparities, and optimizing management of CNS metastases.

Education

2006 Stanford University BA Human Biology
2014 University of California, San Francisco MD Medicine
2015 Kaiser Permanente San Francisco Medical Center Internship Medicine
2015-2019 University of California, San Francisco Residency Radiation Oncology
2017-2018 University of California, San Francisco Chief Resident Radiation Oncology
 

Professional Experience

2019-Present University of California, San Francisco Clinical Instructor Radiation Oncology
2019-Present University of California, San Francisco Director of Quality Assurance Radiation Oncology
 

Awards & Honors

2011 Dean’s Summer Research Fellowship
2013 Young Physician’s Award for Patient Safety - Lucian Leape Institute
2014 Alpha Omega Alpha Medical Honor Society


Recent Significant Publications:

Boreta L, Gadzinski AJ, Wu SY, Xu M, Greene K, Quanstrom K, Nguyen HG, Carroll PR, Hope TA, Feng FY. Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage Radiotherapy. Urology. 2019;129:165-71. doi: 10.1016/j.urology.2018.12.055. PubMed PMID: 30928607

Boreta L, Yom SS. Is there a benefit to locally consolidative therapy for oligometastatic non-small cell lung cancer? Ann Transl Med. 2017;5(5):108. doi: 10.21037/atm.2017.01.21. PubMed PMID: 28361073.

Magnuson WJ, Lester-Coll NH, Wu AJ, Yang TJ, Lockney NA, Gerber NK, Beal K, Amini A, Patil T, Kavanagh BD, Camidge DR, Braunstein SE, Boreta LC, Balasubramanian SK, Ahluwalia MS, Rana NG, Attia A, Gettinger SN, Contessa JN, Yu JB, Chiang VL. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naive Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis. J Clin Oncol. 2017;35(10):1070-7. doi: 10.1200/JCO.2016.69.7144. PubMed PMID: 28113019.

Singer L, Sharee K, Boreta L, Silveira WR, Braunstein S, Fogh S. Quality Improvement Initiative to Improve Tobacco Cessation Efforts in Radiation Oncology. J Oncol Pract. 2019;15(4):e382-e8. doi: 10.1200/JOP.18.00593. PubMed PMID: 30908138.

Weinberg BD, Boreta L, Braunstein S, Cha S. Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma. J Neurooncol. 2018;138(3):549-56. doi: 10.1007/s11060-018-2822-8. PubMed PMID: 29546530

Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach M, 3rd, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA. Impact of Staging (68)Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer. Urology. 2019;125:154-62. doi: 10.1016/j.urology.2018.09.038. PubMed PMID: 30580002.

Wu SY, Boreta L, Wu A, Cheung JP, Cunha JAM, Shinohara K, Chang AJ. Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy. Brachytherapy. 2018;17(2):259-64. doi: 10.1016/j.brachy.2017.10.014. PubMed PMID: 29203149

Wu SY, Singer L, Boreta L, Garcia MA, Fogh SE, Braunstein SE. Palliative radiotherapy near the end of life. BMC Palliat Care. 2019;18(1):29. doi: 10.1186/s12904-019-0415-8. PubMed PMID: 30904024

Xu MJ, Kornberg Z, Gadzinski AJ, Diao D, Cowan JE, Wu SY, Boreta L, Spratt DE, Behr SC, Nguyen HG, Cooperberg MR, Davicioni E, Roach M, 3rd, Hope TA, Carroll PR, Feng FY. Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer. Eur Urol Oncol. 2019. doi: 10.1016/j.euo.2018.11.002. PubMed PMID: 31411984.

Durazzo T, Abadjian L, Kinkaid A, Bilovsky-Munis T, Boreta L, Gauger G. The influence of chronic cigarette smoking on neurocognitive recovery after mild traumatic brain injury. Journal of Neurotrauma.2013 Feb

 

.